Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Title
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Authors
Keywords
Direct-Acting Antiviral Agent, Shortened Duration Therapy, Clinical Trial, Comparison
Journal
GASTROENTEROLOGY
Volume 153, Issue 1, Pages 113-122
Publisher
Elsevier BV
Online
2017-04-06
DOI
10.1053/j.gastro.2017.03.047

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now